China Health Group Ltd
HHKEX:6730.27
HKD
+0.00
(-1.85%)
ISIN
BMG2107P2040
CUSIP
G2107P204
Return %
Stock
S&P 500
1Y
-40.45
14.20
3Y
-74.55
81.12
5Y
-54.04
68.34
Capital Structure
HKD
•
in mil. unless spec.Working Capital
HKD
•
in mil. unless spec.Growth Rates
HKD
•
in mil. unless spec.Semi-annual Revenue
HKD
•
in mil. unless spec.Semi-annual Earnings Per Share
HKD
•
in mil. unless spec.Semi-annual Dividends Per Share
HKD
•
in mil. unless spec.Company Description
- CEO
- Ho Chung
- Full Time Employees
- 111
- Sector
- Distribution services
- Industry
- Medical distributors
- Address
- China Insurance Group Building Hong Kong Hong Kong
- IPO Date
- Oct 14, 1996
- Website
- ch-groups.com
- Similar Companies
- Business
- China Health Group Limited (0673.HK) is a Hong Kong-based investment holding company principally engaged in the distribution and services of medical equipment and consumables in the People's Republic of China. The company operates through four main segments: Distribution and Service in Medical Equipment and Consumables, which includes trading of medical equipment, consumables, and pharmaceutical products; Hospital Operation and Management Services, encompassing the management of facilities such as Shuangluan District People's Hospital, Anping Bo'ai Hospital, Luanping County Red Cross Hospital, and Hong Fu Eldercare and Nursing Home; Business Service, involving property investment and factoring services; and Research and Development and Sale of Functional Food. It pursues a hospital investment management model under the Jingming management mode, integrating digital smart healthcare, supply chain services, physician alliances, education and training platforms, and investment financing; key subsidiaries include China Health Group Health Industry (Shenzhen) Co., Ltd., China Health Group International Finance Lease (Shenzhen) Co., Ltd., and China Health Group Ganfu Equity Investment Management (Xiamen) Co., Ltd. The company targets public, private, and regional hospitals across North China, East China, and South China, with operations radiating nationwide from a base in Shenzhen and leveraging Hong Kong's capital markets for mergers, acquisitions, and trusteeships of second-class or above medical institutions. Incorporated in 2001 and headquartered at Unit 801, 8/F, China Insurance Group Building, 141 Des Voeux Road Central, Hong Kong, it was formerly known as China HealthCare Holdings Limited before changing its name in September 2015. Recent developments include the lapse in June 2025 of a major transaction to acquire 100% equity in ProteinT (Tianjin) Diagnostic Co., Ltd., with no material adverse impact on operations; ongoing loan recovery efforts as supplemented in the annual report for the year ended March 31, 2025; and a reported net sales revenue decline of 35.02% alongside total assets decrease of 23.38% in fiscal 2025, reflecting challenges in its healthcare distribution and management activities.